![Isoniazid Mediates the CYP2B6*6 Genotype-Dependent Interaction between Efavirenz and Antituberculosis Drug Therapy through Mechanism-Based Inactivation of CYP2A6]()
Isoniazid Mediates the CYP2B6*6 Genotype-Dependent Interaction between Efavirenz and Antituberculosis Drug Therapy through Mechanism-Based Inactivation of CYP2A6Court, M. H.; Almutairi, F. E.; Greenblatt, D. J.; Hazarika, S.; Sheng, H.; Klein, K.; Zanger, U. M.; Bourgea, J.; Patten, C. J.; Kwara, A. · Antimicrobial Agents and Chemotherapy · 2014